IIPTA Article Archive
Magnify your Career, Income, Brand and Reach through Intellectual Property.
Subscribe To Get Updates.
Relief for Cancer patients Or Worries for Indian Government?
Chain Reaction : Major Drug Makers cuts price of Cancer Drugs: Just a day after German Giant –Bayer Corp. filed an appeal with IPAB against the grant of C.L . to Indian generic company [...]
How Indian Celebrities are protected by IP Laws?
Protecting Celebrity rights under IP laws is a significant development in the field of IPR. The identity of an individual refers to all distinct, recognizable elements which make up a particular persona, including the [...]
BLOCKBUSTER DRUG MARKET SMASHED BY GENERIC VERSIONS
The global pharmaceutical market is witnessing a change as many patents of key blockbuster drugs have expired in last few years. The patent expiration of blockbuster drug fuel the growth of global generic drug [...]
Bayer Corp. Filed An Appeal against Nexavar
Patent is an exclusive right granted by the government to an inventor for a limited period of time in exchange of complete disclosure of invention. Compulsory License is an important provision under the amended [...]
Infosys growing patent portfolio
THE IMPORTANCE OF PATENT FILLING Sustained economic growth over more than a decade has raised visions of India becoming one of the largest and most important economies in the world. The outsourcing of important [...]
Battle between Indian Companies and Global Giants
The ultra powerful pharmaceutical multi nationals are facing a setback due to India’s weak patent regime for medicines. India has been favoring the low cost Indian generic companies. Also, recently the Indian patent office [...]